Insider · CIK 0001456750

KIM DENNIS D

Reports to the SEC for 4 companies · LA JOLLA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001456750

Forms 4 and 5

Insider transactions

39 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-04-17	CymaBay Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−112K sh	$9.54	−$1.07M	20,000
2023-04-17	CymaBay Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+112K sh	$4.37	+$490K	132,219
2023-04-17	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−112K sh	—	—	169,900
2023-04-13	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−7,781 sh	—	—	282,119
2023-04-13	CymaBay Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+7,781 sh	$4.37	+$34K	27,781
2023-04-13	CymaBay Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−7,781 sh	$8.98	−$69.9K	20,000
2023-03-28	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−100 sh	—	—	289,900
2023-03-28	CymaBay Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+100 sh	$4.37	+$437	20,100
2023-03-28	CymaBay Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−100 sh	$8.98	−$898.5	20,000
2023-01-25	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+180K sh	—	—	180,000
2022-01-25	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+133K sh	—	—	133,333
2022-01-19	CymaBay Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+20K sh	$3.04	+$60.8K	20,000
2021-05-17	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+390K sh	—	—	390,000
2021-05-17	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+10K sh	—	—	10,000
2020-08-07	SKYESkye Bioscience, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+4M sh	—	—	4,736,541
2019-08-21	SKYESkye Bioscience, Inc. · Employee Stock Options (Right to Buy)A Award	Chief Medical Officer	AAward	+737K sh	—	—	736,541
2019-01-22	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+95K sh	—	—	95,000
2018-02-22	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+125K sh	—	—	125,000
2017-07-11	LRMRLarimar Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+10K sh	$3.39	+$33.9K	21,443
2017-05-11	LRMRLarimar Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+9,800 sh	$4.40	+$43.1K	11,443
2017-05-10	LRMRLarimar Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+200 sh	$4.40	+$880	1,643
2017-01-27	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+88K sh	—	—	88,000
2016-03-31	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+37.5K sh	—	—	37,500
2016-03-31	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+75K sh	—	—	75,000
2015-09-17	LRMRLarimar Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,142 sh	$1.57	+$14.4K	9,142
2015-09-17	LRMRLarimar Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−9,142 sh	$40.00	−$366K	0
2015-09-17	LRMRLarimar Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−9,142 sh	$40.00	−$366K	0
2015-09-17	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,142 sh	—	—	103,312
2015-09-15	LRMRLarimar Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−30.3K sh	$40.00	−$1.21M	0
2015-09-15	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−30.3K sh	—	—	112,454
2015-09-15	LRMRLarimar Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−30.3K sh	$40.00	−$1.21M	0
2015-09-15	LRMRLarimar Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+30.3K sh	$1.57	+$47.5K	30,265
2015-09-14	LRMRLarimar Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−593 sh	$40.00	−$23.7K	0
2015-09-14	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−593 sh	—	—	142,719
2015-09-14	LRMRLarimar Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−593 sh	$40.00	−$23.7K	0
2015-09-14	LRMRLarimar Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+593 sh	$1.57	+$931.01	593
2015-02-27	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+90K sh	—	—	281,509
2009-04-23	Orexigen Therapeutics, Inc.Stock option (right to buy)A Award	Sr. VP, Corporate Development	AAward	+44.9K sh	—	—	44,936
2009-03-24	Orexigen Therapeutics, Inc.A Award	Sr. VP, Corporate Development	AAward	+10K sh	$2.65	+$26.5K	25,200

Recent filings

Accepted (ET)
Apr 174
KIM DENNIS D0001062993-23-009245
SEC(opens sec.gov)
Mar 304
KIM DENNIS D0001062993-23-008102
SEC(opens sec.gov)
Jan 274
KIM DENNIS D0001062993-23-001494
SEC(opens sec.gov)
Jan 274
KIM DENNIS D0001062993-22-001699
SEC(opens sec.gov)
Jan 204
KIM DENNIS D0001062993-22-001295
SEC(opens sec.gov)
May 174
KIM DENNIS D0001062993-21-004767
SEC(opens sec.gov)
Aug 114
KIM DENNIS D0001640334-20-002025
SEC(opens sec.gov)
Aug 234
KIM DENNIS D0001640334-19-001745
SEC(opens sec.gov)
Jan 244
KIM DENNIS D0000899243-19-001926
SEC(opens sec.gov)
Feb 234
KIM DENNIS D0000899243-18-005337
SEC(opens sec.gov)
Jul 124
ZAFGEN, INC.0000899243-17-018210
SEC(opens sec.gov)
May 114
ZAFGEN, INC.0000899243-17-012901
SEC(opens sec.gov)

Companies

Address

C/O OREXIGEN THERAPEUTICS, INC. 3344 N. TORREY PINES COURT, SUITE 200

LA JOLLA, CA, 92037